Apellis Pharmaceuticals, Inc. earnings per share and revenue

APLS earnings per share for the last quarter are -0.29 USD whereas the estimation was -0.37 USD which accounts for 21.51% surprise. Company revenue for the same period amounts to 212.53 M USD despite the estimated figure of 198.80 M USD. Estimated earnings per share for the next quarter are -0.34 USD, and revenue is expected to reach 198.27 M USD. Also watch annual changes over time to get a bigger picture of APLS earnings per share and revenue dynamics.